These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23560380)

  • 1. T(2)-weighted combined with diffusion-weighted images for evaluating prostatic transition zone tumors at 3 Tesla.
    Ren J; Yang Y; Zhang J; Xu J; Liu Y; Wei M; Ge Y; Huan Y; Larson AC; Zhang Z
    Future Oncol; 2013 Apr; 9(4):585-93. PubMed ID: 23560380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of transitional zone prostate cancer from benign hyperplasia nodules: evaluation of discriminant criteria at multiparametric MRI.
    Chesnais AL; Niaf E; Bratan F; Mège-Lechevallier F; Roche S; Rabilloud M; Colombel M; Rouvière O
    Clin Radiol; 2013 Jun; 68(6):e323-30. PubMed ID: 23528164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
    Kim CK; Park BK; Lee HM; Kwon GY
    Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging.
    Liu X; Zhou L; Peng W; Wang C; Wang H
    Magn Reson Imaging; 2013 Oct; 31(8):1318-24. PubMed ID: 23791546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results.
    Kim CK; Park BK; Han JJ; Kang TW; Lee HM
    J Comput Assist Tomogr; 2007; 31(3):449-54. PubMed ID: 17538295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer.
    Haider MA; van der Kwast TH; Tanguay J; Evans AJ; Hashmi AT; Lockwood G; Trachtenberg J
    AJR Am J Roentgenol; 2007 Aug; 189(2):323-8. PubMed ID: 17646457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical value of 3 tesla diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer].
    Shimamoto T; Ashida S; Yamasaki I; Kuno T; Fukuhara H; Fukata S; Satake H; Tamura K; Karashima T; Kamata M; Inoue K; Shuin T; Kariya S; Ogawa Y
    Hinyokika Kiyo; 2012 Mar; 58(3):143-8. PubMed ID: 22495042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of prostate cancer and stromal hyperplasia in the transition zone with histogram analysis of the apparent diffusion coefficient.
    Xiaohang L; Bingni Z; Liangping Z; Weijun P; Xiaoqun Y; Yong Z
    Acta Radiol; 2017 Dec; 58(12):1528-1534. PubMed ID: 28286980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
    Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
    AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An intravoxel incoherent motion diffusion-weighted imaging study of prostate cancer.
    Shinmoto H; Tamura C; Soga S; Shiomi E; Yoshihara N; Kaji T; Mulkern RV
    AJR Am J Roentgenol; 2012 Oct; 199(4):W496-500. PubMed ID: 22997399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI.
    Iyama Y; Nakaura T; Katahira K; Iyama A; Nagayama Y; Oda S; Utsunomiya D; Yamashita Y
    Eur Radiol; 2017 Sep; 27(9):3600-3608. PubMed ID: 28289941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
    Kim CK; Park BK; Kim B
    AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted MRI for differentiation of benign from malignant lesions in the gallbladder.
    Lee NK; Kim S; Kim TU; Kim DU; Seo HI; Jeon TY
    Clin Radiol; 2014 Feb; 69(2):e78-85. PubMed ID: 24290779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors.
    Tamada T; Sone T; Jo Y; Hiratsuka J; Higaki A; Higashi H; Ito K
    AJR Am J Roentgenol; 2011 Aug; 197(2):408-14. PubMed ID: 21785087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging.
    Manenti G; Squillaci E; Di Roma M; Carlani M; Mancino S; Simonetti G
    Radiol Med; 2006 Dec; 111(8):1124-33. PubMed ID: 17171522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma.
    Ren J; Huan Y; Li F; Wang H; Ge Y; Chang Y; Yin H; Sun L
    J Magn Reson Imaging; 2009 Aug; 30(2):351-6. PubMed ID: 19591203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
    Rosenkrantz AB; Kong X; Niver BE; Berkman DS; Melamed J; Babb JS; Taneja SS
    AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.